Associate Director, Biology

The role

The Associate Director will contribute to biologic discovery projects by designing, overseeing and interpreting in vitro studies. This person will provide scientific expertise to cross-functional project teams to support key program objectives.

What you will do

• Provide scientific leadership in the planning, execution, and interpretation of data in biologics discovery programs.
• Critically evaluate scientific literature, synthesize novel hypotheses and design rigorous experimental strategies to test them.
• Drive scientific rigor in building and validating disease-relevant in vitro models.
• Contribute to the identification and analysis of biomarkers to support assessment of target engagement, pathway modulation and disease modification.
• Support the identification, characterization, and selection of lead molecules to advance pipeline programs.
• Communicate project progress and key findings effectively in cross-functional meetings.
• Foster a collaborative and accountable team culture.

Required qualifications

• D. in Biology, Pharmacology, Biomedical Sciences, or a related field.
• 10 -12 years of related work experience.
• At least 5 years of experience working within the biotechnology or pharmaceutical research industry.
• Extensive hands-on expertise developing cell-based models of human diseases to understand disease biology, target validation, mechanisms of action and candidate characterization.
• Demonstrated ability to think critically and independently, propose innovative scientific approaches, and apply strong analytical and problem-solving skills to complex biological questions.
• Experience working with contract research organizations (CROs).
• Outstanding communication skills—both written and verbal.

Benefits

• Comprehensive benefits
• Competitive compensation packages

About the company

Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. The company targets fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis.